Log in to search using one of your social media accounts:

 

HRT raises the risk of hearing loss by up to 21%

A study by doctors in Boston, US, found women who take hormone replacement therapy to cope with menopause increase their chances of hearing loss by up to 21 per cent.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Conclusions: Female sex hormones are important for the preservation of lung function in middle aged women. The accelerated lung function decline with menopause is likely caused by decreasing estrogen levels.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Epidemiology Source Type: research
New research in rats by Wake Forest in North Carolina found bioengineering artificial ovaries could provide a safer and more natural hormone replacement therapy for women.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Many women experiencing menopause have mood swings, forgetfulness and weight gain. Could an implant be a safer alternative to hormone replacement therapy?
Source: New Scientist - Health - Category: Consumer Health News Source Type: research
Publication date: Available online 18 October 2017 Source:The Journal of Steroid Biochemistry and Molecular Biology Author(s): Hai Jiang, Wenpei Bai, Wenjuan Wang, Ke Wang, Jing Jia, Jing Zhang, He Diao, Lihua Qin The menopausal period, an inevitable physiological process for women, is frequently associated with physiological and psychological dysfunction attributable to substantial fluctuation and gradual decrease in female hormones induced by ovarian failure, leading to corresponding symptoms and diseases that impact multiple systems in the body to varying degrees. As prior studies have focused primarily on menopausal s...
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research
Hormone replacement therapy may protect short term memory loss caused by stress in menopausal women, new research from the University of Southern California suggests.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Hormone replacement therapy and your heart Long-term hormone replacement therapy used to be prescribed routinely for postmenopausal women to relieve hot flashes and other menopause symptoms. Hormone replacement therapy also was thought to reduce the risk of heart disease. However, research results have been mixed, including one trial that found a small increase in heart [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news
Breast cancer is the most frequent cancer among women especially in the Western world where, despite improved survival, it is one of the leading causes of death (1). Furthermore, for several decades there has been an increase in incidence, though recently there seems to be a stabilization in risk or even a small decline in typical high-risk areas such as Europe and the USA but at the same time a steep increase in typical low-risk societies such as Japan (2). Breast cancer is often regarded as a singular disease, but recent discoveries are pointing to a variety of types of potentially different etiology. Thus, the female...
Source: Scandinavian Journal of Work, Environment and Health - Category: Occupational Health Tags: Editorial Source Type: research
Abstract Hot flushes affect 70% of menopausal women and are reported as being the most bothersome symptom by the majority. Hormone replacement therapy and other currently available alternative therapies are not without side-effects and/or have variable efficacy, and so an effective novel therapy could be practice-changing. Over the last 20 years, numerous studies in animal and human models have implicated neurokinin B, a hypothalamic neuropeptide, together with its receptor (NK3R) in the etiology of menopausal hot flushes. Most recently, a randomized, placebo-controlled trial of an NK3R antagonist in symptomatic m...
Source: Climacteric - Category: Geriatrics Authors: Tags: Climacteric Source Type: research
MN, 50 years old, BMI: 36. Menopause was 7 years ago. No hormone replacement therapy before. She was treated for breast cancer and stopped using tamoxifen two years ago. Asymptomatic. She underwent to a screening transvaginal ultrasound that showed an endometrial thickness of 0.6  cm. Diagnostic hysteroscopy visualized two endometrial polyps. Surgical hysteroscopy was performed with The Integrated Bigatti Shaver (IBS®). The IBS® consists in a 6° angle telescope with an integrated sheath and a working channel in which a rigid shaver system is inserted.
Source: The Journal of Minimally Invasive Gynecology - Category: OBGYN Authors: Source Type: research
Authors: Gambacciani M, Biglia N, Cagnacci A, DI Carlo C, Caruso S, Cicinelli E, DE Leo V, Farris M, Gambera A, Guaschino S, Lanzone A, Paoletti AM, Russo N, Vicariotto F, Villa P, Volpe A Abstract In the last decade the risk benefits ratio of HRT has been reevaluated mainly in tens of cardiovascular risk. Present Consensus Statement is largely inspired by the Global Consensus on Menopausel Hormone Therapy in 2013 and 2016 by leading global menopause societies (The American Society for Reproductive Medicine, The Asia Pacific Menopause Federation, The Endocrine Society, The European Menopause and Andropause Society,...
Source: Minerva Ginecologica - Category: OBGYN Tags: Minerva Ginecol Source Type: research
More News: Health | Hormone Replacement Therapy | Hormones | Men | Menopause | Study | Women